Jack was diagnosed with a rare, incurable blood cancer which research then showed had a 5 year outlook for symptomatic patients requiring treatment. Recently, he was diagnosed with a serious metastatic prostate cancer now in treatment. Travel with Jack on an intensely personal and oft- humorous bumpy ride on the road to Personalized Medicine still under construction. Encounter some relapsed/refractory detours, conflicting signals and biomarkers, inhibiting regulatory roadblocks and potholes in the healthcare system. Learn why Jack, not much of beer drinker himself hangs a bottle of Guinness beer on his infusion rack. Using business skills from his career as a Wall Street Research Analyst in Information Technology and Sales VP he helps bridge the communications gap between life sciences, medical pros and patients as a Research Advocate. A passionate, fun speaker and enthusiastic, credible advocate for patients, you’ll find Jack on the road speaking at medical, biotech and pharma conferences, and global advocacy conferences. He prepares custom compelling messages for his audience. He will shake you and change many of your pre-conceived notions. Jack is recognized as a thoughtful Patient Opinion Leader (POL) and Research Advocate global markets. Some of the topics for which Jack has developed a deep personal interest and knowledge include the ePatient, Clinical Trials, Personalized Medicine, Patient and Research Advocacy and Healthcare Disparities. As an active advocate in Legislative circles, Jack has testified before State and Federal Government lawmakers concerned with Oral Chemotherapy Parity, Step aka “fail first” Therapy, Specialty Tiers, Biosimilars and Companion Diagnostics CDx. He is active with LLS, AACR, ASCO, DIA, RDLA, ACRES, RAN and BIO’s advocacy groups and completed professional advocacy programs provided by these organizations.
Listed skills include Public Speaking, Healthcare, Biotechnology, Clinical Trials, and 45 others.
